Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04770012 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

AERIAL Trial: Antiplatelet Therapy in Heart Transplantation

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv7
  2. Primary completion date: Dec 2024 to Mar 2027
    • Study completion date: Jun 2025 to Mar 2029
    v6
  3. Primary completion date: Jun 2024 to Dec 2024
    • Study completion date: Dec 2024 to Jun 2025
    v5
  4. Primary completion date: Nov 2023 to Jun 2024
    • Study completion date: May 2024 to Dec 2024
    v4
  5. Site details revised at 2 of 3 sitesv3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 3
    • Start date changed from estimate of May 2021 to Jun 28, 2021
    • Study title expanded, about 2 words
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Cardiac allograft vasculopathy is a common complication affecting heart transplant patients. This condition causes narrowing of the heart arteries leading to graft dysfunction. The research team is investigating whether early antiplatelet therapy post heart transplant can prevent the development of CAV. This study will determine the feasibility of a large multicenter randomized placebo-controlled trial to answer this question.
Trial Details
NCT Number NCT04770012
Lead Sponsor Ottawa Heart Institute Research Corporation
Collaborators: Canadian Institutes of Health Research (CIHR)
Conditions
(from sponsor)		 Cardiac Allograft Vasculopathy, Heart Transplant
Enrollment 135 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov